Sara R. Fagerlie, PhD, CHCP

@cancercommunicator.com

Founder of CancerCommunicator.com - Dedicated to improving the care of patients with cancer through news and clinician education.

Stability is paramount to care for elderly Americans. Medicare Advantage plans without guardrails do not provide that. Patient wellbeing is not the goal of for-profit insurers.https://www.healthcaredive.com/news/humana-2027-medicare-advantage-plan-exits-q2-2026/826441/

The first volunteer was vaccinated against Ebola only 68 days after the WHO declared the current outbreak a public health emergency of international concern We spoke to the study's lead scientists about how they were able to move so fast go.nature.com/4x7jMN0

Inside the high-stakes race to develop an Ebola vaccine for an escalating outbreak

The University of Oxford has already vaccinated its first clinical-trial participant. The study’s lead scientist Teresa Lambe tells Nature how they were able to move so fast.

go.nature.com

NYSNA has also voiced concerns with Datavant’s reported ties to Palantir ..The Datavant-powered National COVID Cohort Collaborative Privacy-Preserving Record Linkage runs off a Palantir scientific computing platform, Palantir Foundry,

AI is replacing nurses in NY. I fear the same fate for KY. | opinion

Replacing human nurses with AI is absurd, but it's happening in New York, with technology provided by a company with significant penetration in KY.

courier-journal.com

Among participants 4 to 66 years of age with acquired hypothalamic obesity, setmelanotide, a melanocortin-4 receptor agonist, led to significantly greater reductions in body-mass index and hunger than placebo at 52 weeks. Read the full TRANSCEND trial results: https://nej.md/3Rm9E3L

"the American Astronomical Society said the endeavor cannot be considered to serve the public interest and would waste taxpayer $ by wrecking the work of federally funded astronomical facilities even as it brought untold risks to people and wildlife" Gift article. www.nytimes.com/2026/07/10/c...

F.C.C. Approves Test of Space Mirror to Light Night Sky Despite Outcry (Gift Article)

A start-up company has permission to try its plan to bounce solar rays onto the dark side of Earth, turning night to day for a three-mile-wide patch.

nytimes.com

"The [AI] tool checks every application’s title, abstract and other summary sections for terms including ‘racism’, ‘fossil fuel’, ‘queer’ and ‘sexual minorit’" after passing 2 rounds of peer review, and after programme officials and the relevant institute director have agree #medsky #NIH

Max Kozlov@maxkozlov.bsky.social · last mo.

NIH grants have been under political scrutiny since early 2025. But what does the screening process actually look like? What is being flagged? I spent a month digging into leaked docs and emails. We've published the 235-word list that are being flagged by an internal AI tool. And so much more. 🧵

Talquetamab–daratumumab, with or without pomalidomide, led to longer progression-free survival than daratumumab-based standard care in relapsed or refractory myeloma. More than 75% of patients had grade 3 or higher adverse events. Full MonumenTAL-3 trial results: https://nej.md/4ojBcCL #EHA2026

This image contains two Kaplan-Meier graphs comparing progression-free survival between different treatments over 36 months. Graph A shows "Tal-DP" and "DPd" treatment groups. Graph B shows "Tal-D" and "DPd" treatment groups. Both graphs display confidence intervals. The number of patients at risk is listed below each graph at different time points.

"The shortage began earlier in 2026 after a major manufacturer stopped shipments to correct an issue. Limited alternatives have not fully met clinical demand" the shortage is expect to last through Q4 2026. #medsky www.acr.org/News-and-Pub...

ACR Flags Breast Biopsy Needle Shortage, Urges Collaboration

ACR warns a breast biopsy needle shortage may disrupt care through 2026 and is urging FDA, industry and providers to coordinate.

acr.org